Observational studyOrphanet journal of rare diseases2021

Long-term experience with triheptanoin in 12 Austrian patients with long-chain fatty acid oxidation disorders.

Thomas Zöggeler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.